Other functions preclinical in vitro and in vivo agent development assays contract orientation meeting with NCI, office of acquisitions
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,329
Award facts
- Contract value 100% obligated
- $2,329.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN26100001 worth?
The government has obligated $2,329 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a delivery order under HHSN261201200021I, an indefinite delivery contract, on Preclinical Agent Development Assays 2012-2016.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award